2014

1. Bevacizumab in combination with FOLFIRI in the first-line treatment of patients with advanced colorectal cancer: A single-institution experience

   Journal of Analytical Oncology, Vol. 3, Núm. 1, pp. 26-32

2. Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: Biological basis and therapeutic strategies

   Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 339-350